Insider Cluster (3 insiders) ·Filed Jun 5, 2026

INSM

INSMED Inc
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago
Insider cluster: 3 insiders, $1.3M total
Actionable Insight • Neutral

This cluster is too small relative to market cap to warrant a directional trade. Monitor for any upcoming INSM earnings or pipeline catalysts that could explain the timing, but treat these sales as routine portfolio diversification. No bearish signal.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
INSM ▲ +29.03% at T+60d
NEUTRAL call ✓ call won +29.03% · α vs SPY +25.98% · entry $94.17 → $121.51
Entry anchored
Jun 5, 2026
via day open
T+1d
+5.17%
call +5.17% · α +5.47%
$99.04
settled 4mo ago
T+5d
+3.49%
call +3.49% · α +1.38%
$97.46
settled 4mo ago
T+20d
+18.45%
call +18.45% · α +16.81%
$111.54
settled 3mo ago
T+60d
+29.03%
call +29.03% · α +25.98%
$121.51
settled 4w ago

Price Chart

Loading chart...

Executive Summary

Three top INSM insiders—CEO, CFO, and CMO—collectively sold $1.29M in open-market sales over a 7-day window. The total value is ~0.006% of INSM's $22.7B market cap, well below the 0.1% materiality threshold, making this a routine liquidity-driven cluster. Historical calibration shows prior INSM reports have underperformed significantly (avg T+20 alpha -21.65%), reinforcing that this filing warrants a neutral, low-impact read.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
3

Key Facts

  • CEO Lewis William sold 7,605 shares for ~$778K on June 3, 2026
  • CFO Bonstein Sara sold 2,404 shares for ~$246K on June 3, 2026
  • CMO Flammer Martina sold 4,424 shares total (~$455K) across June 3 and June 5, 2026
  • Total cluster value of $1.29M represents ~0.006% of INSM's $22.7B market cap
  • All sales were open-market (code S), with no 10b5-1 plan disclosure in the filing

Financial Impact

Total insider sales of $1.29M, equivalent to ~0.006% of market cap — immaterial

insider ownershipfloat

Risk Factors

  • Insider sales could accelerate if a negative catalyst (e.g., FDA setback) emerges, but current volume is negligible
  • Historical INSM reports show poor predictive accuracy (0% win rate at T+20), so even a larger cluster would need independent confirmation

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
97% bullish (29 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INSM-1780690509017
18 reports for INSM
Performance horizon
86% Hit rate 6 of 7 directional calls best @ T+60▲ +31.86%Mar 30, 2026
Filters
Rows
Reports for INSM — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$130.66 $119.92▼ −8.22%▼ −6.70%$109.99 (−15.82%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$126.33 $129.41▲ +2.44%▲ +4.19%$109.99 (−12.93%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 8/10
$132.55 $126.68▼ −4.43%▼ −5.03%$109.99 (−17.02%)
Jul 24, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$106.92 $125.77▲ +17.63%▲ +14.00%$109.99 (+2.87%)
Jul 21, 2026
10w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$108.62 $128.46▲ +18.27%▲ +15.70%$109.99 (+1.26%)
Jul 16, 2026
11w ago
8-K
BULLISH ★ 6/10
$107.46 $126.33▲ +17.56%▲ +13.94%$109.99 (+2.35%)
Jun 26, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$104.74 $106.92▲ +2.08%▲ +2.36%$109.99 (+5.01%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$109.99 (+16.80%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$109.99 (+16.80%)
May 15, 2026
19w ago
S-3ASR
NEUTRAL ★ 3/10
$107.15 $95.52▼ −10.85%▼ −12.44%$109.99 (+2.65%)
Showing 10 of 18

US Market Status

Market Open — Closes in 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 5, 2026